Welcome to the Breast Cancer Alliance!

 The mission of the Breast Cancer Alliance is to improve survival rates and quality of life for those impacted by breast cancer through better prevention, early detection, treatment and cure.  To promote these goals, we invest in innovative research, breast surgery fellowships, regional education, dignified support and screening for the underserved. 

 

 

Read More

2015 Site Visits

Each year, in accordance with our commitment to due diligence, we visit each of the institutions to whom we provide a grant allocation.  Dates for each of these visits are posted below, and new ones will be added as they become available.  If you would like to attend any of these visits, please email yonni@breastcanceralliance.org to reserve your spot.

We are thrilled to announce that Breast Cancer Alliance awarded nearly $1.6M in grants for 2015


 

May 27 at 3pm

Edward Gunther, MD, “Interclonal Cooperation in Models of Hormone-Dependent Breast Cancer, ” Penn State College of Medicine

May 28 at 11am

Chi Dang, MD, PhD and Lin Zhang, MD,  “Long non-coding RNAs (lncRNAs) in Breast Cancer,” University of Pennsylvania

June 1 at 10:30am

Rachelle Leong, MD, Mt. Sinai Beth Israel

June 8 at 12pm

Greenwich Hospital, Greenwich, CT

June 9  at 9:30am

Hanna Irie, MD, PhD and Elisa Port, MD, “Patient-Derived Tumor Xenograft (PDX) Models as a Predictive Tool for Cytoxic Treatment Response and Therapeutic Resistance for Triple-Negative Breast Cancer (TNBC)” and Ming Ming Zhou, PhD, “New Targeted Epigenetic Therapy for Triple-Negative Breast Cancer (TNBC),” Icahn School of Medicine at Mt. Sinai

June 11 at 11am

Rebecca Fishman, MD, Rutgers Cancer Institute of New Jersey 

June 16 at 9:30am

Gilda’s Club, White Plains, NY

June 17 at 11am

White Plains Hospital, White Plains, NY

June 19 at 10:30am

Joseph John Weber, MD, Memorial Sloan-Kettering Cancer Center 

June 23 at 10am

Ann’s Place, Danbury, CT

Griffin Hospital, Derby, CT

July 16 at 11am

Gail Sonnenshein, PhD, “ADAM8 – A Driver of Metastasis, is a Validated New Target for Treatment of Triple-Negative Breast Cancer (TNBC),” Tufts University School of  Medicine    

September 9 at 11am     

Norma F. Pfriem Breast Care Center and The Witness Project, Fairfield, CT         

 

Read More

Latest Videos

 

Read More